ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | ![](/images/5605/15397_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins
| | | | ![](/images/1528/4689_A_1_5_rna_selected_60x60.jpg) | Expressed in all |
ATP5J | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 | Mitochondrial proteins Plasma proteins
| | | | ![](/images/31069/65266_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ATXN3 | Ataxin 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| ![](/images/21976/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/21976/48176_A_3_5_rna_selected_60x60.jpg) | Expressed in all |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | ![](/images/2572/6946_B_1_6_rna_selected_60x60.jpg) | Expressed in all |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | ![](/images/10807/25954_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | ![](/images/19918/47053_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | ![](/images/27421/57220_B_2_7_rna_selected_60x60.jpg) | Expressed in all |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | ![](/images/443/1114_B_2_5_rna_selected_60x60.jpg) | Mixed |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| ![](/images/29003/ihc_selected_60x60.jpg) | | | ![](/images/29003/123910_B_8_8_rna_selected_60x60.jpg) | Mixed |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Transcription factors
| ![](/images/49117/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/49117/110537_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
BCL2 | B-cell CLL/lymphoma 2 | Cancer-related genes Disease related genes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| ![](/images/3/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/3/1332_B_2_6_rna_selected_60x60.jpg) | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | ![](/images/27770/57596_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
BIN2 | Bridging integrator 2 | Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/38667/106333_A_3_5_rna_selected_60x60.jpg) | Mixed |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | ![](/images/41937/90336_B_1_6_rna_selected_60x60.jpg) | Expressed in all |
BTF3 | Basic transcription factor 3 | Plasma proteins
| | | | ![](/images/56420/136162_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/1198/2772_A_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
C11orf30 | Chromosome 11 open reading frame 30 | Plasma proteins
| ![](/images/12234/ihc_selected_60x60.jpg) | | | ![](/images/12234/33168_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | ![](/images/26483/if_selected_60x60.jpg) | | ![](/images/26483/54897_A_9_4_rna_selected_60x60.jpg) | Expressed in all |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/926/2497_B_8_8_rna_selected_60x60.jpg) | Tissue enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/6558/22094_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CA3 | Carbonic anhydrase III, muscle specific | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21775/48848_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins
| | | | ![](/images/6/1322_A_8_6_rna_selected_60x60.jpg) | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/7790/19565_B_3_4_rna_selected_60x60.jpg) | Expressed in all |
CALR | Calreticulin | Cancer-related genes Plasma proteins Predicted secreted proteins
| ![](/images/2242/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/2242/8395_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CALU | Calumenin | Plasma proteins Predicted secreted proteins
| | | | ![](/images/6018/18211_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/4738/11906_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
CAPG | Capping protein (actin filament), gelsolin-like | Plasma proteins
| | | | ![](/images/19092/44173_A_3_5_rna_selected_60x60.jpg) | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | ![](/images/5992/16387_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
CAPN2 | Calpain 2, (m/II) large subunit | Enzymes Plasma proteins
| ![](/images/24470/ihc_selected_60x60.jpg) | | | ![](/images/24470/53622_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
CAPNS1 | Calpain, small subunit 1 | Plasma proteins
| | ![](/images/6872/if_selected_60x60.jpg) | | ![](/images/6872/18747_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/26624/56299_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | ![](/images/8381/20561_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
CAST | Calpastatin | Cancer-related genes Plasma proteins
| ![](/images/36881/ihc_selected_60x60.jpg) | | | ![](/images/9491/32218_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/18433/42080_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/1223/5627_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CBX3 | Chromobox homolog 3 | Plasma proteins
| | | | ![](/images/4902/16165_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | ![](/images/3804/10590_B_7_2_rna_selected_60x60.jpg) | Expressed in all |
CCT2 | Chaperonin containing TCP1, subunit 2 (beta) | Plasma proteins
| | | | ![](/images/3197/9748_A_1_8_rna_selected_60x60.jpg) | Expressed in all |
CCT3 | Chaperonin containing TCP1, subunit 3 (gamma) | Cytoskeleton related proteins Plasma proteins
| ![](/images/6543/ihc_selected_60x60.jpg) | | | ![](/images/6543/19261_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
CCT5 | Chaperonin containing TCP1, subunit 5 (epsilon) | Disease related genes Plasma proteins
| | | | ![](/images/6271/18268_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CCT7 | Chaperonin containing TCP1, subunit 7 (eta) | Plasma proteins
| | ![](/images/8425/if_selected_60x60.jpg) | | ![](/images/8425/23297_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
CCT8 | Chaperonin containing TCP1, subunit 8 (theta) | Plasma proteins
| | ![](/images/29426/if_selected_60x60.jpg) | | ![](/images/29426/63704_A_3_7_rna_selected_60x60.jpg) | Expressed in all |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2420/6095_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD33 | CD33 molecule | CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/11442/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/35832/113042_A_9_5_rna_selected_60x60.jpg) | Mixed |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/5785/16382_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2497/6307_A_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/26494/54991_A_6_5_rna_selected_60x60.jpg) | Expressed in all |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | ![](/images/10088/26866_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/51/217_B_7_6_rna_selected_60x60.jpg) | Expressed in all |